Civic AI
Civic AI
Procurement intelligence
SAM.govNIH-NOI-26-PCA-NIDCR-01222
Open

BD FACSDiscover� S8 Cell Sorter

Response deadline
Jun 25, 2026
Closed
Date posted
Jun 15, 2026

Description

Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations (OLAO) For: National Institute of Dental and Craniofacial Research (NIDCR) Division of Intramural Research (DIR) Combined Technical Research Core (CTRC) 2. Action Being Announced This is a notice of intent, and not a request for competitive quotations, proposals, or bids. The National Institutes of Health (NIH), on behalf of the National Institute of Dental and Craniofacial Research (NIDCR), intends to negotiate and award a firm-fixed-price sole source contract to: Becton, Dickinson and Company / BD Biosciences for the acquisition of one (1) BD FACSDiscover� S8 Cell Sorter, including required configuration, delivery, installation, biosafety-compliant hood, and standard warranty coverage. Project Number: PCA-NIDCR-01222 Project Title: BD FACSDiscover� S8 Cell Sorter 3. Statutory Authority The Government intends to award this requirement on a sole source basis pursuant to: 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements; and as applicable to this acquisition, 41 U.S.C. 1901 and FAR 13.501(a)(1)(ii). This requirement will be processed as an open-market acquisition. 4. Description of Requirement The National Institute of Dental and Craniofacial Research (NIDCR), Division of Intramural Research (DIR), Combined Technical Research Core (CTRC), requires the acquisition of a highly specialized commercial laboratory instrument to replace aging and end-of-life cell sorting instruments and to provide advanced capabilities necessary to support current and future NIH intramural research. The required instrument must provide, at a minimum, the following capabilities: Cell sorting capability for high-parameter research applications; Spectral flow cytometry capability; Integrated real-time imaging during acquisition and/or sorting; Ability to analyze and sort cells based on fluorescence/spectral signatures, morphology, and image-derived parameters; Support for rare-cell sorting; Support for index sorting and plate sorting; and A biosafety-compliant configuration suitable for sorting human cells in NIH research environments. The anticipated delivery period is 60 to 90 days after award for delivery, installation, and acceptance. The acquisition includes a one-year warranty following installation and acceptance.

Classifications

Documents

No documents posted for this opportunity.

Similar contracts

Explore more